Scholars@Duke
Rani Bansal

Rani Bansal

Assistant Professor of Medicine
Medicine, Medical Oncology
Box 3381, Seeley Mudd Building, Durham, NC 27710

Scholarly Works - Journal articles

Evaluation of efficacy and safety of sequential antibody drug conjugates (ADCs) in human epidermal growth factor 2 (HER2)-negative metastatic breast cancer.

Journal article Breast Cancer Res Treat · December 2025 PURPOSE: Limited data is available assessing sequencing of antibody drug conjugates (ADCs) in patients with hormone receptor-positive (HR +), human epidermal growth factor 2 (HER2)-negative, HER2-low, and triple-negative metastatic breast cancer (MBC), inc ... Full text Link to item Cite

A comprehensive evaluation of de novo metastatic breast cancer trends by subtype from the Dallas Metastatic Cancer Study.

Journal article Commun Med (Lond) · August 5, 2025 BACKGROUND: The Dallas Metastatic Cancer Study is a clinical database established to examine local trends associated with the diagnosis and treatment of de novo metastatic breast cancer and identify factors for further evaluation. Clinical characteristics ... Full text Link to item Cite

Comparison of survival outcomes for patients with Stage III vs de novo Stage IV breast cancer.

Journal article Cancer · May 15, 2025 PURPOSE: Improvements in systemic therapy have resulted in significant heterogeneity in survival outcomes for metastatic breast cancer patients. As such, recently proposed staging guidelines for de novo metastatic breast cancer stratify patients into four ... Full text Link to item Cite

Genomic and transcriptomic landscape of HER2-low breast cancer.

Journal article Breast Cancer Res Treat · January 2025 BACKGROUND: Novel agents have expanded the traditional HER2 definitions to include HER2-Low (HER2L) Breast Cancer (BC). We sought to evaluate the distinct molecular characteristics of HER2L BC to understand potential clinical/biologic factors driving resis ... Full text Link to item Cite

Impact of systemic therapy after stereotactic radiosurgery in patients with limited brain-only metastasis.

Journal article Neurooncol Adv · 2025 BACKGROUND: The impact of systemic therapy (ST) on outcomes for patients with brain-only metastases (BrM) in the absence of extracranial disease (ECD) is not well established. We compared outcomes between patients with BrM treated with stereotactic radiosu ... Full text Link to item Cite

Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers.

Journal article Commun Med (Lond) · December 2, 2024 BACKGROUND: Breast and prostate tumors are known to be less responsive to immune checkpoint inhibitors (ICIs). Tissue-based tumor mutation burden (tTMB) has emerged as a predictive biomarker of response to ICIs, including in these "cold tumors". In clinica ... Full text Link to item Cite

Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted Therapy.

Journal article JCO Precis Oncol · December 2024 PURPOSE: Malignant phyllodes tumors (MPTs) are rare fibroepithelial tumors of the breast with aggressive biologic behavior and high recurrence rates. Surgery remains the primary treatment modality for these tumors; however, initial investigations suggest a ... Full text Link to item Cite

Final results of BrUOG 354: A randomized phase II trial of nivolumab alone or in combination with ipilimumab for people with ovarian and other extra-renal clear cell carcinomas.

Journal article Journal of Clinical Oncology · June 10, 2024 LBA5500Background: Extra-renal clear cell cancer (CCC) are rare tumors that can arise from any organ. Gynecologic CCC can originate from the ovaries, endometrium, or cervix. Compared to serous carcinomas, ovarian ... Full text Cite

Cardiovascular impact of near complete estrogen deprivation in premenopausal women with breast cancer: The CROWN study.

Journal article Am Heart J · January 2024 Survival with operable breast cancer has improved markedly in recent decades, however, treatment-related cardiovascular toxicities threaten to offset these gains. Ovarian function suppression paired with aromatase inhibition, for premenopausal women with h ... Full text Link to item Cite

Evaluating Patient Experience in a Multidisciplinary Breast Cancer Clinic: A Prospective Study.

Journal article J Womens Health (Larchmt) · January 2024 Background: Multidisciplinary clinics (MDCs) are a care model in which patients see several physicians across specialties and/or other allied health professionals in a single appointment in a shared space. This study sought to better understand patients' e ... Full text Link to item Cite

Triple Negative Breast Cancer and Brain Metastases.

Journal article Clin Breast Cancer · December 2023 The treatment of metastatic breast cancer (MBC) has improved over the past decade, however prognosis continues to be mitigated by the fact that about 1 in 5 patients with MBC will develop brain metastases (BrM) during their metastatic disease course. 1 Thi ... Full text Link to item Cite

Vaccines in Gastrointestinal Malignancies: From Prevention to Treatment.

Journal article Vaccines (Basel) · June 13, 2021 Gastrointestinal (GI) malignancies are some of the most common and devastating malignancies and include colorectal, gastric, esophageal, hepatocellular, and pancreatic carcinomas, among others. Five-year survival rates for many of these malignancies remain ... Full text Link to item Cite

Targeted therapies for gastroesophageal cancers.

Journal article Ann Transl Med · September 2020 Gastroesophageal cancers are some of the most common malignancies worldwide. A significant portion of patients are diagnosed with advanced or metastatic disease given the insidious nature of gastroesophageal cancers. In the instance where surgical resectio ... Full text Link to item Cite

Black Patients Experience Highest Rates of Cancer-associated Venous Thromboembolism.

Journal article Am J Clin Oncol · February 2020 PURPOSE: Cancer patients are at a higher risk of venous thromboembolism (VTE) than the general population. In the general population, blacks are at a higher risk of VTE compared with whites. The influence of race on cancer-associated VTE remains unexplored ... Full text Link to item Cite

Race/Ethnicity, Primary Language, and Income Are Not Demographic Drivers of Mortality in Breast Cancer Patients at a Diverse Safety Net Academic Medical Center.

Journal article Int J Breast Cancer · 2015 Objective. To examine the impact of patient demographics on mortality in breast cancer patients receiving care at a safety net academic medical center. Patients and Methods. 1128 patients were diagnosed with breast cancer at our institution between August ... Full text Link to item Cite